Harvard College Admissions Rate Falls to 5.9 Percent for Class of 2016

Acceptances issued for class of 2016

Harvard College announced today that 2,032 applicants had been offered admission to the class of 2016, entering this August—5.9 percent of 34,302 applicants.

The admissions rate last year was 6.2 percent (2,158 offers of admission extended to 34,950 applicants).

It may seem paradoxical that fewer applicants were offered admission, pushing the acceptance rate down, in a year when the total pool of would-be Harvardians decreased by about 2 percent. But that reflects the reinstatement of early-action admissions, which attracted more than 4,200 applications by the deadline last November, and the decision, announced last December, to admit 772 of those candidates—the equivalent of nearly half an entering class. Admissions officers expect the “yield” (student acceptance of Harvard’s offer of admission) to be higher for the early-action pool than for candidates filing under the regular deadline; to ensure that enrollment does not exceed the College’s capacity, they had to reduce the admission rate for the rest of the pool (although not as drastically as the Crimson estimated earlier this week).

The College’s news release cited the challenges this posed:

With the return of early action this year, it is more difficult than in the past to predict how many admitted students will accept Harvard’s offer of admission. “We have always been conservative about the number of acceptances sent out at this time of year in order to avoid the possibility of overcrowding. Harvard’s high graduation rate—typically 97 to 98 percent—leaves little margin for error,” said William R. Fitzsimmons, dean of admissions and financial aid. “As always, we expect to use the waiting list….”

All admitted students have until May 1 to indicate their acceptance or rejection of Harvard’s offer of admission; the “Visitas” visiting period for those accepted applicants who wish to kick the tires in Cambridge falls on the weekend of April 21 to 23.

Read the news release here.

Yale admitted 6.8 percent of applicants (1,975 of 28,974); the Yale Daily News published a useful chart showing many peer schools' admission rates. Princeton admitted 7.9 percent of applicants (2,095 of 26,664). Stanford admitted 6.6 percent of applicants (2,427 of 36,631). Among the leading, selective research universities reporting, all almost all set a record low for their rate of admissions this year.

Reflecting wide interest in elite institutions' admissions decisions, "The Choice," a New York Times blog on admisssions and financial aid, is inviting applicants to post comments as they receive e-mail notifications today

Updated April 2,2012, at 1:00 p.m. to incorporate admissions data from other universities.

You might also like

Sustainability on the Menu

Harvard’s sustainable meals program aims to support local farms, protect oceans, and limit waste.

What of the Humble Pencil?

Review: At the Harvard Art Museums’ new exhibit, drawing takes center stage

Harvard Research Funding Will Resume, Government Signals

Notices of grant reinstatements follow a court ruling, but the Trump administration could still appeal. 

Most popular

Two Years of Doxxing at Harvard

What happens when students are publicly named and shamed for their views?

A New Narrative of Civil Rights

Political philosopher Brandon Terry’s vision of racial progress

Paolo Pasco and the Art of Making Crosswords

Paolo Pasco and the art of making crosswords

Explore More From Current Issue

Man splashing water on his face at outdoor fountain beside woman holding cup near stone building.

Why Heat Waves Make You Miserable

Scientists are studying how much heat and humidity the human body can take.

Nineteenth-century prison ruins with brick guardhouse surrounded by forest.

This Connecticut Mine Was Once a Prison

The underground Old New-Gate Prison quickly became “a school for crime.”

Illustration of scientists injecting large syringe with mitochondria into human heart.

Do Mitochondria Hold the Power to Heal?

From Alzheimer’s to cancer, this tiny organelle might expand treatment options.